A Status of Drugs on the Horizon for Obesity and the Metabolic Syndrome—a Comprehensive Review 2005

摘要: Obesity is increasing in prevalence and its medical liabilities are, large measure, related to the metabolic syndrome, a syndrome of insulin resistance. The drugs available at present for treatment obesity are few number limited efficacy. This chapter reviewed approved other indications that cause weight loss, late development process have not been approved, earlier stages drug which clinical information limited, dropped from development, new potential targets essentially no data yet exist. We also nonprescription products sold syndrome. pipeline rich. Because treat being developed an era characterized by more sophisticated tools than existed when hypertension were developed, much faster progress developing safe effective anticipated. With available, we anticipate chronic with loss medication will become as well accepted prevalent diabetes practice today.